Anticancer activity evaluation of green synthesised gold–silver alloy nanoparticles on colourectal HT-29 and prostate DU-145 carcinoma cell lines

Anticancer activity evaluation of green synthesised gold–silver alloy nanoparticles on colourectal HT-29 and prostate DU-145 carcinoma cell lines

For access to this article, please select a purchase option:

Buy article PDF
(plus tax if applicable)
Buy Knowledge Pack
10 articles for $120.00
(plus taxes if applicable)

IET members benefit from discounts to all IET publications and free access to E&T Magazine. If you are an IET member, log in to your account and the discounts will automatically be applied.

Learn more about IET membership 

Recommend Title Publication to library

You must fill out fields marked with: *

Librarian details
Your details
Why are you recommending this title?
Select reason:
Micro & Nano Letters — Recommend this title to your library

Thank you

Your recommendation has been sent to your librarian.

Nanotechnology is an interesting way to produce and deal with fascinating features of materials. Metal nanoparticles offer a vast spectrum of potential applications in medicine and pharmaceutical sciences due to advances in nanotechnology research. This study was aimed to evaluate the anticancer properties of gold–silver (Au–Ag) alloy nanoparticles, which were synthesised using a green method by Galega officinalis ethanolic extract. The antitumour activity of biosynthesised nanoparticles has been assessed in vitro using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay on DU-145 and HT-29, prostate and colon cell lines, respectively. The Au–Ag alloy nanoparticles activity to inhibit the growth of cancer cell lines was recorded in terms of decrease in viable cell count in comparison with the control value. The spherical Au–Ag alloy nanoparticles with average size of 100 nm diameter were synthesised. The growth inhibition of the human prostate (DU-145) and colon carcinoma cell line (HT-29) has been found to be dose dependent. The calculated IC50 for the DU-145 cell line was 95.78 μg/ml after 24 h and for the HT-29 cell line was 70.66 µg/ml after 48 h. The results of this study suggest that Au–Ag alloy nanoparticles could be as an active substance against tumour cell lines and may be a beneficial treatment for cancer.


    1. 1)
    2. 2)
    3. 3)
      • 3. Köhler, M., Fritzsche, W.: ‘Nanotechnology: an introduction to nanostructuring techniques’ (Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2007, 2nd edn.).
    4. 4)
    5. 5)
    6. 6)
    7. 7)
      • 7. Qu, D., Sun, W., Chen, Y., et al: ‘Synthesis and in vitro antineoplastic evaluation of silver nanoparticles mediated by Agrimoniae herba extract’, Int. J. Nanomed., 2014, 9, pp. 18711882.
    8. 8)
    9. 9)
      • 9. Devi, J.S., Bhimba, B.V., Ratnam, K.: ‘Invitro anticancer activity of silver nanoparticles synthesized using the extract of Gelidiella sp.’, Int. J. Pharm. Pharm. Sci., 2012, 4, pp. 710715.
    10. 10)
    11. 11)
      • 11. Kanchana, A., Balakrishna, M.: ‘Anti-cancer effect of saponins isolated from Solanum trilobatum leaf extract and induction of apoptosis in human larynx cancer cell lines’, Int. J. Pharm. Pharm. Sci., 2011, 3, (4), pp. 356364.
    12. 12)
    13. 13)
    14. 14)
    15. 15)
    16. 16)
    17. 17)
    18. 18)
    19. 19)
    20. 20)
      • 20. Scudiero, D.A., Shoemaker, R.H., Paull, K.D., et al: ‘Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines’, Cancer Res., 1988, 48, (17), pp. 48274833.
    21. 21)
    22. 22)
    23. 23)
    24. 24)
    25. 25)
    26. 26)
    27. 27)
    28. 28)
    29. 29)
    30. 30)
    31. 31)
    32. 32)
    33. 33)
      • 33. Sergent, J.A., Paget, V., Chevillard, S.: ‘Toxicity and genotoxicity of nano-SiO2 on human epithelial intestinal HT-29 cell line’, Ann. Occup. Hyg., 2012, 56, (5), pp. 622630.
    34. 34)
    35. 35)
    36. 36)
    37. 37)
    38. 38)
    39. 39)
    40. 40)

Related content

This is a required field
Please enter a valid email address